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Nuclear replication of DNA viruses activates DNA damage repair (DDR) pathways, which are thought to
detect and inhibit viral replication. However, many DNA viruses also depend on these pathways in order
to optimally replicate their genomes. We investigated the relationship between murine polyomavirus
(MuPyV) and components of DDR signaling pathways including CHK1, CHK2, H2AX, ATR, and DNAPK. We
found that recruitment and retention of DDR proteins at viral replication centers was independent of
H2AX, as well as the viral small and middle T-antigens. Additionally, infectious virus production required
ATR kinase activity, but was independent of CHK1, CHK2, or DNAPK signaling. ATR inhibition did not
reduce the total amount of viral DNA accumulated, but affected the amount of virus produced, indicating
a defect in virus assembly. These results suggest that MuPyV may utilize a subset of DDR proteins or non-
canonical DDR signaling pathways in order to efﬁciently replicate and assemble.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Robust replication and repair of DNA is required to maintain
the integrity of the cellular genome. DNA damage repair (DDR)
pathways protect the genome from mutation by repairing lesions
from endogenous and exogenous DNA damage. In mammalian
cells, ataxia-telangiectasia mutated (ATM) kinase, ataxia-tel-
angiectasia and Rad3 related (ATR) kinase and DNA dependent
protein kinase (DNA-PK) are the phosphatidylinositol 3-kinase-
related kinases (PIKKs) that activate DDR proteins and induce
checkpoint signaling when cellular DNA damage occurs (Ciccia and
Elledge, 2010). The ATM and DNA-PK pathways are activated pri-
marily in response to double strand breaks, which are detected
and bound by the Mre11-Rad50-Nbs1 (MRN) or Ku70/80 complex
(Lee and Paull, 2004; Mahaney et al., 2009; Stracker and Petrini,
2011). ATR kinase is activated in response to single stranded DNA
lesions bound by the replication protein A (RPA) complex (Cim-
prich and Cortez, 2008; Zou and Elledge, 2003). ATM, ATR, and
DNA-PK also phosphorylate H2AX (γH2AX) to maintain repair
enzymes around break sites, and checkpoint kinases, CHK1 and
CHK2, to prevent progression of the cell cycle while repair occurs
(Bassing et al., 2002; Celeste et al., 2003; Cimprich and Cortez,
2008; Matsuoka et al., 2007).
In addition to their role in cellular DNA damage, these DDR
pathways are often activated by viruses that replicate andInc. This is an open access article u
Garcea).assemble in the nucleus, resulting in a complex interplay between
DDR pathways and viral replication. These cellular DDR pathways
can both promote and inhibit viral replication and assembly.
Herpes Simplex Virus 1 (HSV-1) utilizes a subset of DDR proteins,
including ATM kinase and Mre11, to replicate its viral genome,
while degrading others such as RNF8 and RNF168 (Lilley et al.,
2005, 2011). DDR pathways have also been implicated as a host
cell defense that distinguishes between viral genomes and cellular
DNA. For example, during adenovirus (Ad5) infection, the cellular
MRN complex acts as a potent inhibitor of viral DNA replication,
but speciﬁc viral gene products, E4ORF3 and E1B55k, counteract
this inhibition by degrading the MRN complex (Carson et al., 2003;
Evans and Hearing, 2005; Stracker et al., 2002). The different in-
teractions between DNA viruses and DDR proteins are related both
to the structure of the viral genome (circular versus linear) and the
phase of the cell cycle during which these viruses replicate
(Chaurushiya and Weitzman, 2009; Lilley et al., 2007).
Polyomaviruses (PyVs) are small dsDNA viruses with circular
genomes that replicate in the nucleus. The murine polyomavirus
(MuPyV) genome has six gene products, three early T-antigen
proteins (small, middle, and large) and three late proteins (VP1,
VP2, and VP3). The T-antigen (Tag) proteins prime the cell for viral
DNA replication through interactions with host proteins. Small
T-antigen (ST) binds to PP2A and modulates the phosphorylation
of cellular proteins, including mitogen activated kinase (MAPK)
and AKT (Andrabi et al., 2007; Arroyo and Hahn, 2005). Middle
T-antigen (MT) is a membrane bound protein that activates sig-
naling pathways through interactions with phosphatidylinositidender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1983; Fluck and Schaffhausen, 2009). Large T-antigen (LT) drives
cell cycle progression into S-phase through interactions with host
proteins, such as phosphorylated retinoblastoma protein (Rb)
(Sheng et al., 1997; Zalvide et al., 1998). Additionally, it is thought
that LT binds to DDR proteins, including a component of the MRN
complex, Nbs1, and the RPA complex to manipulate the host cell
DDR to enhance viral DNA replication (Banerjee et al., 2013; Wu
et al., 2004).
DDR pathways are activated when PyVs replicate in the nu-
cleus. For example, SV40, BKPyV, and MuPyV activate and utilize
ATM kinase signaling for efﬁcient replication (Dahl et al., 2005;
Jiang et al., 2012; Sowd et al., 2013). In cells infected by PyVs, DDR
proteins co-localize at nuclear sites of viral DNA replication
(Erickson et al., 2012; Jiang et al., 2012; Orba et al., 2010; Tsang
et al., 2014). MuPyV utilizes ATM signaling to regulate the cell
cycle and maintain a prolonged S-phase (Dahl et al., 2005). SV40
requires both ATM and ATR kinase activity to replicate circular,
monomeric viral genomes. Following inhibition of ATM or ATR,
SV40 infected cells accumulate concatemerized and damaged viral
genomes that cannot be packaged into virions (Sowd et al., 2013,
2014). SV40 LT induces the proteasome-dependent degradation of
the MRN complex, an activator of ATM kinase (Zhao et al., 2008).
These ﬁndings suggest that some proteins in the ATM pathway are
required, while others may inhibit PyV replication.
The roles of DDR pathways and proteins during viral replication
are complex because each virus may have particular requirements
for replication and assembly. We investigated speciﬁc components
of the ATM and ATR pathways in order to further elucidate the role
of DDR proteins during MuPyV infection. We analyzed the re-
cruitment of DDR proteins, such as Mre11 and RPA32, to nuclear
viral replication centers, as well as the functional requirement for
ATR and checkpoint signaling in MuPyV virus production. Finally,
we evaluated DDR signaling and viral replication center formation
in cells infected with mutant viruses that do not express ST or MT.2. Methods
2.1. Cell lines and infections
C57BL/6 mouse embryonic ﬁbroblasts (MEF) were obtained
from ATCC (SCRC-1008; Manassas, VA) and served as a wild-type
(WT) MEF. MEFs were grown in DMEM (D6429, Sigma) supple-
mented with 10% fetal bovine calf serum (FBS; F0926, Sigma), and
55 μM β-mercaptoethanol (βME) at 37 °C with 5% CO2. Virus strain
NG59RA (Feunteun et al., 1976) was used for all WT virus infec-
tions. Cells were plated for 24 h, then cultured in DMEM supple-
mented with 0.5% serum for 24 h, before infections were carried
out in adsorption buffer (Hanks Balanced Salt Solution (HBSS) with
10 mM HEPES, pH 5.6% and 0.5% BCS) as previously described
(Cripe et al., 1995). Cells were infected for 2 h at a multiplicity of
infection of approximately 10–15 pfu/cell, and then cultured in
DMEM supplemented with serum for the remainder of the ex-
periment. CHK2-null and syngeneic control cells were a gift from
Tak Mak. H2AX-null and syngeneic WT controls were a gift from
Andre Nussenzweig. CHK2 and H2AX-null cells and their syn-
geneic WT cells were grown in DMEM supplemented with 10%
bovine calf serum (BCS), 55 μM βME and penicillin/streptomycin
at 37 °C with 5% CO2.
2.2. Immunoﬂuorescence
Cells were plated on acid-etched coverslips and infected as
described above. Coverslips were washed twice with 4 °C phos-
phate buffered saline (PBS), pre-extracted with 0.5% Triton X-100in CSK Buffer (10 mM piperazine-1,4-bis(2-ethanesulfonic acid)
(PIPES), pH 6.8, 100 mM NaCl, 300 mM sucrose, 1 mM MgCl2,
1 mM EGTA) on ice for 5 min, washed twice with 4 °C PBS, and
ﬁxed with 4% paraformaldehyde (PFA) for 10 min at room tem-
perature (RT). Following an overnight block in 10% BCS, coverslips
were incubated with primary antibody at 37 °C for 1 h, washed
three times with 10% BCS in PBS, then incubated for 1 h at RT with
secondary antibodies. Slides were washed three times in PBS and
then mounted in ProLong antifade reagent containing DAPI (In-
vitrogen) and allowed to cure at 22 °C for 24–48 h.
2.3. Immunoﬂuorescence antibodies
Primary antibodies used for immunostaining were rat anti-Tag
(E1, a gift from Tom Benjamin) (Goldman and Benjamin, 1975)
1:5000; rabbit anti-VP1 (Montross et al., 1991) 1:5000, rabbit anti-
pCHK1 (s345, Cell Signaling) 1:1000; mouse anti-pATM (ser1981,
Abcam) 1:1000; rabbit anti-Mre11a (B1447; LSBio) 1:1000; rat
anti-RPA32 (4E4, a gift from Heinz Nasheuer) 1:5; and rat anti-
pSer23 RPA32 (a gift from Heinz Nasheuer) 1:20. For RPA32 co-
staining with rat anti-Tag antibody, the E1 Tag antibody was
conjugated with AlexaFluor 647 (Invitrogen) and was used at a
1:1000 dilution. All other primary antibodies were detected using
secondary antibodies, conjugated with AlexaFluor 488, AlexaFluor
546, or AlexaFluor 647 (Invitrogen), diluted 1:2000. All primary
and secondary antibodies were diluted in 10% BCS in PBS.
2.4. Fluorescent in Situ Hybridization (FISH) of MuPyV DNA
The entire MuPyV genome (NG59RA) was cloned into pUC18
and a FISH probe was generated by nick translation of pUC18-
MuPyV plasmid using Promoﬂuor-550 NT Labeling Kit (PK-PF550-
NTLK) according to manufacturer's instructions. FISH analysis was
performed as described previously (Jul-Larsen et al., 2004), with
modiﬁcations. Brieﬂy, cells grown on coverslips were infected,
ﬁxed and immunostained for viral or host proteins, as described
above. Immunostained cells were ﬁxed a second time with 4% PFA
in PBS to crosslink bound antibodies, followed by treatment with
0.2 mg/ml RNase Type III (Sigma) in 2X SSC at 37 °C for 15 min and
washed three times in 2x SSC. The FISH probe was diluted in
cDenHyb (InSitus). The probe was hybridized with samples for
3 min at 90 °C, for 2 min each at 80 °C, 70 °C, 60 °C, 50 °C, 45 °C,
and ﬁnally overnight at 37 °C. Coverslips were washed at 45 °C
with 1.5x SSC, 50% formamide/1.5x SSC for 5 min and 1.5x SSC for
5 min. Coverslips were washed twice for 5 min in PBS at RT.
Stained cells were mounted onto glass slides with ProLong anti-
fade reagent containing Dapi (Invitrogen) and allowed to cure at
22 °C for 24–48 h.
2.5. EdU labeling
EdU was added to media at ﬁnal concentration of 10 μM at
28 HPI and allowed to incubate for 15 min at 37 °C. Coverslips
were washed once in PBS and immediately ﬁxed and stained, as
described above. The ﬂuorescent dye conjugation reaction was
performed according to manufacturer's protocol (Invitrogen,
C10340).
2.6. Microscopy
Confocal images were acquired on the Nikon A1R laser scan-
ning confocal microscope, using a 1.45NA 100x objective and 405,
488, 561 and 638 laser lines. All images are a single z-plane
through the center of the nucleus. Image processing and analysis
were completed using ImageJ analysis software (NIH).
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Cells were lysed with 2X SDS lysis buffer with phosphatase
inhibitors (25 mM Tris, pH 6.8/1% SDS/6.25 mM EDTA with 1 mM
Na3VO4 and 25 mM NaF) on ice for 15 min followed by a brief
sonication to shear the DNA. The total protein concentration of
each lysate was determined by BioRad DC Protein Assay. Samples
were prepared by dilution in 4x SDS sample buffer (1 M Tris, pH
6.8/2% SDS/12.5 mM EDTA/40% glycerol/600 mM βME/0.02% Bro-
mophenol Blue) and heated at 95 °C for 5 min. 25 mg total protein
was resolved on 8% SDS-polyacrylamide gels and proteins were
electrophoretically transferred to PVDF membranes. Membranes
were blocked in 5% powered milk in TBST (10 mM Tris, pH 8.0,
150 mM NaCl, 0.1% Tween-20) with 1 mM Na3VO4 and 25 mM NaF.
All antibodies except for pCHK1 were incubated at 37 °C with
rocking for 1 h followed by three 20 min washes in TBST with
rocking. The pCHK1 antibodies were incubated at 4 °C with rock-
ing overnight, and then followed the same wash and secondary
antibody protocol. Membranes were incubated with HRP-con-
jugated secondary antibodies (Promega) diluted 1:20,000 in TBST
and washed as described for the primary antibodies. Proteins were
detected using enhanced chemiluminescence (ECL, Pierce) detec-
tion and imaged on the LAS4000 Imager. Image processing and
integrated density analysis were completed using ImageJ analysis
software (NIH).
2.8. Western blot antibodies
Primary antibodies used for western blot were: rabbit anti-
Rad50 (GeneTex, GTX119731) 1:1000; rabbit anti-pCHK1 S317 (Cell
Signaling, 12302P) 1:200; rabbit anti-pCHK1 S296 (Cell Signaling,
2349) 1:1000, rabbit anti-GAPDH (Abcam, 37168) 1:1000; mouse
anti-Tag, PN116 (a gift from Brian Schaffhausen), and 1:250; rabbit
anti-VP1 (I58), 1:5000 (Montross et al., 1991).
2.9. Small molecule inhibitors
All small molecule inhibitors were dissolved in DMSO and di-
luted in DMEM with 0.5% serum to working concentrations and
added to cells at indicated time points: NU7441 (Tocris), 2 μM;
PF477736 (Tocris), 1 μM; and ATR inhibitor IV (VE-821, EMD Mil-
lipore), 5 μM.
2.10. Virus supernatant harvest
Cells (4104 per well) were seeded on a six well dish (9.5 cm2
well) for 24 h, then starved in 0.5%FBS or BCS for 24 h before in-
fection. At this time, the cells were 60–70% conﬂuent. Virus pre-
paration and infection was carried out as described above. After a
2 h incubation with virus, 0.5% serum in DMEM was added for the
remainder of the experiment. At times indicated, supernatants
were transferred to 15 ml conical tubes and saved. Remaining cells
on the plate were treated with 2 units of neuraminidase (NA) Type
V (Sigma) that was diluted in NA buffer (10 mM Hepes, pH 5.6/
1 mM CaCl2/1 mM MgCl2/5 mM KCl) for 30 min at 37 °C. The NA
supernatant was collected and combined with the original su-
pernatant. The plates were washed three times with PBS and each
wash was collected and combined with supernatants. The com-
bined supernatants and washes were stored at 20 °C.
2.11. Immunoplaque assay
WT C57 cells were plated on a 96-well optical imaging dish
(Costar, 9603) for 24 h, then cultured in 0.5% FBS for an additional
24 h. Cells were infected with viral supernatants diluted in ad-
sorption buffer (as described above) at 1:100–1:1000 and infectedin triplicate. Virus was removed after 2 h and DMEMwith 0.5% FBS
was added to cells. At 28–30 HPI, cells were ﬁxed with 4% PFA/PBS
at RT for 10 min, permeabilized with 0.5% Triton X-100/PBS.
Samples were then incubated with anti-Tag and anti-VP1 anti-
bodies at dilutions described for immunoﬂuorescence, followed by
AlexaFluor 488 anti-rabbit, and AlexaFluor 546 anti-rat secondary
antibodies. Nuclei were stained with Hoescht dye diluted in PBS.
Plates were imaged on a Molecular Devices ImageXpress Micro XL
High-Content Screener with a 10 objective. Tag and VP1 positive
nuclei were determined based on the average pixel intensity
within the nuclei, as deﬁned by Hoescht dye staining. Image
analysis was completed using ImageJ analysis software (NIH). An
example of the analysis is outlined in Fig. S1.
2.12. Cell line normalization
For CHK2 control and knockout, and H2AX WT and knockout
comparisons, viral titers and viral DNA accumulation were nor-
malized for the infection level of each individual cell line. Cell line
normalization is described in Fig. S2.
2.13. DNA isolation
Viral DNA was isolated by Hirt extraction (Hirt, 1967), with
modiﬁcations. Brieﬂy, cellular DNA was precipitated in high salt
and remaining supernatants were treated with 10 mg RNase, fol-
lowed by 25 mg of proteinase k. Viral DNA was puriﬁed by phenol-
chloroform extraction and sodium acetate/ethanol precipitation.
The DNA pellet was resuspended in 50 ml Tris-EDTA, diluted 1:200,
and analyzed by qPCR.
2.14. Quantitative PCR (qPCR)
Primer Express 3.0 software (Applied Biosystems, Warrington,
UK) was used to design primers that ampliﬁed of a 67-bp region of
the VP1 gene of the MuPyV genome (NCBI accession #
NC_001515). Primers used for qPCR were: MuPyV VP1 forward
primer, 5′TGGGAGGCAGTCTCAGTGAAA3′ MuPyV VP1 reverse pri-
mer, 5′TGAACCCATGCACATCTAACAGT3′. qPCR reactions were pre-
pared in 96-well optical plates (Applied Biosystems) in a volume of
25 ml. Each reaction contained 450 nM of each forward and reverse
primer, 12.5 ml FastSYBR Master Mix (Applied Biosystems) and 5 ml
puriﬁed viral DNA or DNA standards. DNA ampliﬁcation was car-
ried out using a Biorad CFX96 thermocycler using cycling condi-
tions of 50 °C for 2 min, 95 °C for 10 min followed by 40 cycles of
95 °C for 15 s, 60 °C for 1 min. For each run, triplicates of ﬁve di-
lutions of the viral standard DNA (from 0.5 ng to 8104 ng;
pGEX-VP1 plasmid DNA), viral DNA samples, and no template
controls were simultaneously analyzed.
2.15. Statistical analysis
All error bars are standard error of the mean of three biological
replicates. Statistical signiﬁcance was calculated using a two-tailed
student's t-test assuming unequal variance. p values of o0.05
indicated with *. Non-signiﬁcant differences marked “n.s.”3. Results
3.1. MuPyV recruits DDR proteins to viral DNA replication centers in
the nucleus of infected cells
JCPyV, BKPyV, and SV40 activate and recruit host DDR proteins
to sites of viral replication in the nucleus (Jiang et al., 2012; Orba
et al., 2010; Zhao et al., 2008). Therefore, we characterized nuclear
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Fig. 1. MuPyV activates and reorganizes host DDR proteins in the nucleus. MEFs were infected with WT MuPyV (NG59RA), and ﬁxed, permeabilized, and immunostained at 28 h
post infection (HPI). Single z-plane confocal immunoﬂuorescence images show cells stained for Tag and (A) MuPyV DNA (FISH) (B) RPA32 (C) pSer23 RPA32 (D) pSer345
CHK1 (E) Mre11 (F) pATM or (G) γH2AX. (H) Total proteins were isolated at 28 HPI and analyzed by immunoblot for pSer317 CHK1 and Rad50 protein levels. (I) Quantiﬁcation
of integrated density of pSer317 CHK1 and Rad50 levels in control and infected MEFs normalized to GAPDH loading control. All samples were normalized to the value of the
uninfected control cells.
K. Heiser et al. / Virology 497 (2016) 346–356 349MuPyV viral replication centers in infected mouse embryonic ﬁ-
broblasts (MEFs). The MuPyV LT formed “tracks” throughout the
nucleus that co-localized with replicating viral DNA (Fig. 1A). We
analyzed the localization of DNA repair proteins during infection
and found many that were recruited to these viral replication
centers, including RPA32, and Mre11 (Fig. 1B, E). Additionally, DDR
signaling was active at replication centers, as evidenced byphosphorylated RPA32 (pSer23 RPA32), CHK1 (pCHK1), ATM
(pATM) and H2AX (γH2AX) (Fig. 1C, D, F, G). DDR proteins do not
form similar replication centers in the nucleus of uninfected MEFs
(Fig. S3). These data suggest that MuPyV activates and recruits
DDR proteins similar to other PyVs.
It has been previously reported that SV40 infection activates
DDR signaling and induces the degradation of the MRN complex
K. Heiser et al. / Virology 497 (2016) 346–356350(Zhao et al., 2008). We therefore analyzed immuno-blots of in-
fected cell lysates to determine if levels of MRN proteins were
affected during MuPyV infection. In contrast to SV40, we found
that expression levels of Rad50 and Mre11, members of the MRN
complex, were comparable in mock and infected samples (Figs. 1H
and S4). However, similar to SV40 there was a striking increase in
the amount of pCHK1 in MuPyV infected cells (Fig. 1H). Quantiﬁ-
cation of the immuno-blots revealed an approximately three-fold
increase in pCHK1, but no change in Rad50 levels (Fig. 1I). These
data suggest that MuPyV activates and recruits DDR proteins, but
does not affect their overall expression or stability, in contrast to
observations during SV40 infection.NG18
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Fig. 2. ST and MT are not required for localization of DDR proteins to viral replication cente
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Fig. 3. Mre11 is preferentially recruited to replicating MuPyV DNA during infection. MEFs were infected with NG59RA. At 28 HPI, 10 μM EdU was added to the media. Samples
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were normalized to image maximum for each label.
K. Heiser et al. / Virology 497 (2016) 346–356 351et al., 1989). Interestingly, NG18 replication centers (Fig. 2A) were
smaller than either 808A (Fig. 2A) or WT virus (Fig. 1A). These data
suggest that ST has a role in the expansion of these centers, pos-
sibly through activation of other signaling pathways that aid DNA
replication. However, recruitment of phosphorylated RPA32
(Fig. 2B) and Mre11 (Fig. 2C) were maintained during infection by
808A and NG18 mutant viruses, suggesting that LT is likely theviral protein responsible for recruitment of DDR proteins to viral
replication centers.
3.3. Mre11 is preferentially recruited to replicating viral DNA
Many DDR proteins, such as the MRN complex, have roles in
both the DNA damage response and cellular DNA replication
(Stracker and Petrini, 2011). The MRN complex normally stabilizes
K. Heiser et al. / Virology 497 (2016) 346–356352replication forks at sites of cellular DNA replication (Maser et al.,
2001; Tittel-Elmer et al., 2009). In order to distinguish replicating
viral DNA from replicating cellular DNA we labeled replicating
DNA in infected cells with EdU, and a ﬂuorescent in-situ hy-
bridization (FISH) probe speciﬁc to the MuPyV genome (Fig. 3A).
To determine whether Mre11 was recruited to all actively re-
plicating DNA, we also immunostained for Mre11 and analyzed its
recruitment to replicating host or viral DNA (Fig. 3B). Host cell
DNA replicated during early times after infection and could be
visualized along with replicating viral DNA. During infection,
Mre11 speciﬁcally localized to replicating viral DNA and not re-
plicating cellular DNA (Figs. 3C, D, and S5). Thus, Mre11 is pre-
ferentially recruited to viral replication centers.
3.4. Checkpoint kinases, CHK1 and CHK2, are not required for Mu-
PyV replication
Activation of CHK1 and CHK2 has been observed during JCPyV
and SV40 infection (Boichuk et al., 2010; Orba et al., 2010). It has
been suggested that intra S-phase signaling stalls MuPyV-infected
cells in S or G2 phase, allowing viral replication to proceed for an
extended time (Dahl et al., 2007, 2005). To assess the potential
requirement for CHK1 and CHK2 during MuPyV infection, we
utilized a CHK1 inhibitor (PF477736) or CHK2-null ﬁbroblasts (Fig.
S6). As expected, PF477736 treatment signiﬁcantly reduced CHK1
autophosphorylation at Ser296 during infection (Fig. S7). However,
inhibition of CHK1 using PF477736 did not affect viral titers
(Fig. 4A) or viral DNA replication (Fig. 4B). Additionally, CHK2-null
ﬁbroblasts produced infectious viral progeny (Fig. 4A) and re-
plicated viral DNA at similar levels to syngeneic control (CHK2þ /)
cells (Fig. 4B). These results suggest that, despite robust CHK1
activation during infection, neither CHK1 nor CHK2 kinases are
required for efﬁcient MuPyV replication and assembly.
3.5. H2AX is not required for MuPyV Replication
The histone marker γH2AX is required for maintenance of DDRC
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media for indicated samples at 2 HPI. (A) Viral titers at 48 HPI quantiﬁed by immunop
32 HPI quantiﬁed by qPCR, normalized to the value of the control.proteins at sites of cellular DNA damage and for full activation of
downstream signaling (Bassing et al., 2002; Celeste et al., 2002;
Rogakou et al., 1999). Since γH2AX is present at viral replication
centers (Fig. 1G), we used H2AX-null ﬁbroblasts to determine
whether H2AX is required for viral DNA replication, virus assem-
bly, or DDR signaling during MuPyV infection (Fig. S6) (Celeste
et al., 2002). We found that viral replication centers that formed in
H2AX-null ﬁbroblasts were similar to those observed in WT cells
(Fig. 5A). Additionally, H2AX was dispensable for recruitment of
Mre11 and pCHK1 to viral replication centers (Fig. 5B, C). Inter-
estingly, H2AX-null ﬁbroblasts produced similar outputs of virus to
syngeneic WT cells (Fig. 5D), but replicated approximately two-
fold more viral DNA than WT (Fig. 5E). These data suggest that
although H2AX may affect accumulation of viral DNA, overall it is
not required for MuPyV genome replication and virus assembly.
3.6. ATR signaling is required for virus production, but not viral DNA
replication
During SV40 infection, ATR kinase activity stabilizes and re-
solves viral DNA replication intermediates (Sowd et al., 2013).
Following DNA damage, CHK1 is directly phosphorylated by ATR
and can activate checkpoint signaling (Zhao and Piwnica-Worms,
2001). In contrast, DNA-PK, the DDR kinase associated with non-
homologous end-joining (NHEJ), is not required during SV40 DNA
replication (Sowd et al., 2013). To determine whether ATR activity
or DNA-PK activity are required for MuPyV replication, we utilized
small molecule inhibitors of ATR (VE-821) and DNA-PKcs
(NU7441). As expected, inhibition of ATR resulted in an approx-
imate 50–70% decrease in CHK1 phosphorylation in both control
and infected MEFs (Fig. 6A, B). However, ATR inhibitor treatment
did not affect the recruitment of DDR proteins such as RPA32,
Mre11, and pCHK1, to viral replication centers (Fig. 6C). Interest-
ingly, ATR inhibition reduced virus production (Fig. 6D), but did
not affect replication of viral DNA (Fig. 6E). In contrast, inhibition
of DNA-PK during MuPyV infection did not affect either viral titer
(Fig. 6D) or viral DNA accumulation (Fig. 6E), similar to0.0
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Fig. 5. H2AX is not required for recruitment of DDR proteins, virus production, or viral DNA accumulation during MuPyV infection. H2AX-null (H2AX/) ﬁbroblasts were infected
with NG59RA, and at 28 HPI cells were ﬁxed and immunostained. Single z-plane confocal images of cells stained for (A) Viral DNA and Tag, (B) Viral DNA and Mre11, or (C)
Tag and pCHK1. (D) H2AXWT (H2AXþ /þ) and null (H2AX/) cells were infected with NG59RA. Virus supernatants were harvested at 48 HPI and viral titers were quantiﬁed
by immunoplaque assay, normalized to the value of the control or (E) Viral DNA was harvested at 32 HPI and viral DNA accumulation was quantiﬁed by qPCR, normalized to
the value of the control.
K. Heiser et al. / Virology 497 (2016) 346–356 353observations for SV40. The reduction in viral titer in ATR inhibitor
treated samples was not due to decreased cell viability or a re-
duction in the number of cells expressing Tag (Fig. S8). These re-
sults suggest that ATR signaling, but not DNA-PK activity, may aid
MuPyV in resolving viral DNA replication intermediates, similar to
its role in SV40 DNA replication.4. Discussion
Viruses and host DDR signaling have a complex relationship
that varies signiﬁcantly between different viruses. PyVs have been
shown to inhibit or degrade members of DDR pathways, such as
components of the MRN complex (Wu et al., 2004; Zhao et al.,
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K. Heiser et al. / Virology 497 (2016) 346–356 3552008). Conversely, DDR signaling through the ATM pathway seems
to be ubiquitously required for PyV replication and assembly (Dahl
et al., 2005; Jiang et al., 2012; Shi et al., 2005; Sowd et al., 2013;
Tsang et al., 2014; Zhao et al., 2008). In order to interrogate the
relationship between MuPyV and DDR pathways we utilized
knockout cell lines, small molecule inhibitors, and confocal mi-
croscopy to visualize viral replication centers. We found that
MuPyV MT and ST are dispensable for DDR protein recruitment to
replication centers, and that efﬁcient virus production requires
ATR signaling. Several roles for DDR pathways during PyV infec-
tion have been suggested, including maintenance of the S-phase of
the cell cycle, repair of damaged viral DNA, resolution of replica-
tion intermediates, or a host defense (Dahl et al., 2005; Jiang et al.,
2012; Orba et al., 2010; Sowd et al., 2013; Zhao et al., 2008). Our
results suggest that checkpoint kinase signaling and H2AX phos-
phorylation may be dispensable for MuPyV replication, but ATR
activity is required.
MuPyV ST and MT interact with PP2A and other host proteins
to activate cellular signaling pathways. Mutant viruses lacking ST
and MT have signiﬁcant defects in viral DNA replication and as-
sociated reductions in virus outputs. However, viruses with mu-
tations in MT alone have close to WT levels of DNA accumulation,
but substantially reduced viral titers (Chen et al., 2006; Garcea and
Benjamin, 1983; Garcea et al., 1989). Cells infected by the ST and
MT mutant virus, NG18, had smaller viral replication centers than
cells infected by either WT virus or the MT mutant virus, 808A.
Despite the smaller size, DDR proteins, such as Mre11 and RPA32,
were recruited to WT and mutant virus replication centers. This
observation suggests that recruitment of DDR proteins to replica-
tion centers is mediated through LT. The MuPyV LT may facilitate
recruitment and activation of DDR protein through an interaction
with the RPA complex or NBS1 (Banerjee et al., 2013; Wu et al.,
2004). However, the increased viral DNA accumulation and the
expansion of viral replication centers observed in WT and 808A
infected cells is likely dependent on signaling pathways regulated
by ST, including AKT or MAPK.
Biochemical analysis of SV40 infected cells revealed that in-
hibition of either ATM or ATR increased the accumulation of in-
correctly resolved viral genomes (Sowd et al., 2013). Speciﬁcally,
inhibition of ATM was observed to increase unidirectional fork and
rolling circle replication, while inhibition of ATR showed a slight
increase in these aberrant replication products along with an in-
crease in broken and unrepaired viral genomes (Sowd et al., 2013,
2014). Previous reports have shown a requirement for ATM kinase
in MuPyV replication (Dahl et al., 2005). We found an additional
requirement for ATR signaling during MuPyV infection. ATR in-
hibition signiﬁcantly reduced viral titers, but not total viral DNA
accumulation, suggesting a defect in assembly or egress. It is likely
that ATR inhibitor treatment leads to the formation of viral DNA
concatemers or other viral DNA intermediates that cannot be
packaged into virions, similar to observations for SV40. However,
inhibition of CHK1, a downstream target of ATR, did not affect viral
titers or DNA accumulation indicating that checkpoint signaling
from the ATR pathway is not required for MuPyV replication and
assembly. The defects in viral titers we observed are therefore due
to another function of ATR, such as recruitment or activation of
repair proteins. SV40 LT induces the degradation of the MRN
complex during infection; however, levels of the MRN complex
remained constant during MuPyV infection. This ﬁnding suggests
that although SV40 and MuPyV require ATM and ATR signaling,
there are differences in their interaction with DDR proteins.
MuPyV may utilize signaling through ATM to induce a pro-
longed S-phase in order to efﬁciently replicate (Dahl et al., 2005).
CHK2 is a direct target of ATM kinase and can activate checkpoint
signaling following DNA damage (Ahn et al., 2004). To determine if
activation of checkpoint signaling by CHK2 was required forMuPyV infection, we analyzed CHK2-null MEFs (Hirao et al., 2000)
and found that MuPyV did not require CHK2 in order to efﬁciently
replicate. Additionally, we found that CHK1, a downstream target
of ATR kinase, was not necessary for efﬁcient MuPyV virus pro-
duction. Although we did not observe a requirement for either
CHK1 or CHK2 signaling during infection, it is possible that either
kinase is sufﬁcient to compensate for the other and a combina-
torial inhibition or knockdown would be necessary to observe a
phenotype.
H2AX is a histone variant present in a subset of nucleosomes
and is thought to act as a signal of DNA damage and chromatin
abnormalities. Phosphorylation of H2AX at serine 139 generates
γH2AX, which activates and recruits downstream DDR proteins.
The loss of H2AX during cellular DNA damage results in reduced
DDR mediated checkpoint signaling and reduced retention of DDR
proteins at DNA break sites (Celeste et al., 2003; Fernandez-Ca-
petillo et al., 2002). Interestingly, during MuPyV infection, H2AX is
not required to activate checkpoint kinase CHK1 or to retain DDR
proteins such as Mre11 at viral DNA replication centers. Ad-
ditionally, we found that while H2AX null ﬁbroblasts accumulated
higher levels of viral DNA, there was not a signiﬁcant increase in
viral titer produced by these cells. It has been reported that when
extreme levels of cellular DNA damage occur, H2AX is not required
to maintain downstream signaling (Fernandez-Capetillo et al.,
2002). Therefore, it is possible viral replication induces an “ex-
treme” level of DNA damage, since MuPyV replication activates
CHK1 in the absence of H2AX. However, a more intriguing ex-
planation is that a different mechanism of activation or recruit-
ment of DDR proteins occurs during viral infection than during
cellular DNA damage.
During adenovirus infection, non-canonical DDR pathways are
activated in response to viral DNA replication. A “localized” acti-
vation of DDR signaling occurs at adenovirus (Ad5) replication
centers, which does not induce H2AX phosphorylation (Shah and
O’Shea, 2015). We observed a similar activation of DDR signaling
that was independent of H2AX. This ﬁnding is consistent with
models proposing “global” signaling following cellular DNA da-
mage, and “local” DDR signaling at viral replication centers. These
varying types of DDR signaling may aid the cell in distinguishing
viral DNA from host DNA damage. Our data support the hypothesis
that these local signaling events may not require the same sig-
naling molecules as global cellular DDR. Although MuPyV exploits
some DDR proteins in order to replicate, it does not require many
components of the ATM and ATR pathways, including checkpoint
signaling, a hallmark of canonical cellular DDR signaling. A more
thorough understanding of the mechanism of activation and re-
cruitment of DDR proteins by viral DNA replication is required to
better understand these non-canonical signaling pathways.Footnotes
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